Incorporating the Next Generation of Immunotherapies Into the Treatment of Multiple Myeloma [0.03%]
下一代免疫治疗在多发性骨髓瘤治疗中的应用
Kevin C Miller,Ross S Firestone,Malin Hultcrantz
Kevin C Miller
Immunotherapies have recently changed the treatment landscape of multiple myeloma (MM). CAR T cells and T-cell-redirecting bispecific antibodies (BsAbs) yield impressive responses and extend survival in patients with relapsed/refractory MM....
Real-World Representation in Prostate Cancer Clinical Trials: Needs and Opportunities [0.03%]
前列腺癌临床试验的现实世界代表性：需求与机遇
Hannah D McManus,Daniel J George,Jeffrey W Shevach
Hannah D McManus
Prostate cancer (PC) care has undergone a significant transformation in the past decade, leading to unprecedented survival outcomes, particularly for patients with newly diagnosed metastatic disease. However, there is a sizable gap in effic...
Improving Racial Disparities in Lung Cancer Screening Uptake: A Mixed-Methods Study of a Centralized Program [0.03%]
改善肺癌筛查率中种族差异的混合方法研究：集中式项目的研究
Neelima Navuluri,Tiera Lanford-Davey,Govind Krishnan et al.
Neelima Navuluri et al.
Background: Lung cancer screening (LCS) uptake remains inequitable across the United States, especially among individuals who identify as Black or African American. Synthesized and integrated analyses of quantitative and ...
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology [0.03%]
NCCN泌尿系统肿瘤临床实践指南 : 膀胱癌 2026 v1.2
Thomas W Flaig,Philippe E Spiess,Michael Abern et al.
Thomas W Flaig et al.
The NCCN Guidelines for Bladder Cancer provide strategies for the diagnosis, treatment, and follow-up of patients with bladder cancer, which is the sixth most common cancer in the United States. Bladder cancer can be divided into 3 categori...
Emma M Bradley,Palina Woodhouse,Kelvin A Moses et al.
Emma M Bradley et al.
Background: Breast cancer treatment is complex, incorporating multimodality and preference-sensitive treatments dependent on oncologic characteristics, patient understanding, and shared decision-making. Health literacy (H...
JNCCN Is Moving Online [0.03%]
JNCCN即将整体转型在线
Kimberly Callan,Daniel M Geynisman
Kimberly Callan
Methylphenidate-Type Psychostimulants for Cancer-Related Fatigue: Updated Meta-Analysis of Randomized Controlled Trials [0.03%]
关注癌症相关性疲乏的米拉德明类精神病刺激剂：随机对照试验的更新型荟萃分析
Bruno Almeida Costa,Richard Sheppard,Henrique G B Coelho et al.
Bruno Almeida Costa et al.
Background: Nonpharmacologic interventions are the mainstay of management for cancer-related fatigue (CRF), with few pharmacologic options available-notably methylphenidate (MPH) and dexmethylphenidate (d-MPH). Given mixe...
Adrian E Go,Edward Christopher Dee
Adrian E Go
Daniel E Spratt,Sandy Srinivas,Nabil Adra et al.
Daniel E Spratt et al.
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guideline...